Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 17, Pages 4363
Publisher
MDPI AG
Online
2021-08-30
DOI
10.3390/cancers13174363
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Addressing resistance to immune checkpoint inhibitor therapy – an urgent unmet need
- (2021) Siwen Hu-Lieskovan et al. Future Oncology
- Targeting epigenetic regulatory machinery to overcome cancer therapy resistance
- (2021) Lei Guo et al. SEMINARS IN CANCER BIOLOGY
- Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d/E2F1 axis
- (2021) Xin Lv et al. Aging-US
- Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma
- (2021) Shunsuke Kunou et al. ONCOGENE
- Role of cancer‑associated fibroblasts in the resistance to antitumor therapy, and their potential therapeutic mechanisms in non‑small cell lung cancer (Review)
- (2021) Congcong Chen et al. Oncology Letters
- Therapeutic Targeting of the Tumor Microenvironment
- (2021) Leire Bejarano et al. Cancer Discovery
- miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
- (2021) Maria Teresa Di Martino et al. Cancers
- The Role of Cancer-Associated Fibroblasts in Tumor Progression
- (2021) Rushikesh S. Joshi et al. Cancers
- The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities
- (2021) Christiana M. Neophytou et al. Cancers
- Exosomal lncRNA UCA1 modulates cervical cancer stem cell self-renewal and differentiation through microRNA-122-5p/SOX2 axis
- (2021) Zhihui Gao et al. Journal of Translational Medicine
- Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
- (2021) Khalil Khalaf et al. Frontiers in Immunology
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target
- (2020) Zachary T. Freeman et al. JOURNAL OF CLINICAL INVESTIGATION
- Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells
- (2020) Jing-Quan Wang et al. Cancers
- Fibroblast‑derived exosomal microRNA‑369 potentiates migration and invasion of lung squamous cell carcinoma�cells via NF1‑mediated MAPK signaling pathway
- (2020) Liping Guo et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Mechanisms of Multidrug Resistance in Cancer Chemotherapy
- (2020) Karol Bukowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long non-coding RNAs regulate drug resistance in cancer
- (2020) Kaisheng Liu et al. Molecular Cancer
- Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
- (2020) Yuanjun Lu et al. Molecular Cancer
- A dual PI3 kinase/mTOR inhibitor BEZ235 reverses doxorubicin resistance in ABCB1 overexpressing ovarian and pancreatic cancer cell lines
- (2020) David E. Durrant et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Role of FOXO Transcription Factors in Cancer Metabolism and Angiogenesis
- (2020) Mohd Farhan et al. Cells
- The Role of Tumor-Associated Myeloid Cells in Modulating Cancer Therapy
- (2020) Christiana M. Neophytou et al. Frontiers in Oncology
- CD137 agonist induces gastric cancer cell apoptosis by enhancing the functions of CD8+ T cells via NF-κB signaling
- (2020) Ben-Shun Hu et al. Cancer Cell International
- PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
- (2020) Rui Liu et al. Cell Death & Disease
- Carcinoma-Associated Fibroblasts Promote Growth of Sox2-Expressing Breast Cancer Cells
- (2020) Angela Dittmer et al. Cancers
- Propagation and Maintenance of Cancer Stem Cells: A Major Influence of the Long Non-Coding RNA H19
- (2020) Clément Lecerf et al. Cells
- Loss of microRNA-30e induced by extracellular vesicles from cancer-associated fibroblasts promotes breast cancer progression by binding to CTHRC1
- (2020) Chunfang Xi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The PROTAC technology in drug development
- (2019) Yutian Zou et al. CELL BIOCHEMISTRY AND FUNCTION
- Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
- (2019) Helai P. Mohammad et al. NATURE MEDICINE
- Cancer-associated fibroblasts produce Netrin-1 to control cancer cell plasticity
- (2019) Pei-Ju Sung et al. CANCER RESEARCH
- Aggressive variants of prostate cancer – Are we ready to apply specific treatment right now?
- (2019) Igor Tsaur et al. CANCER TREATMENT REVIEWS
- Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
- (2019) In-Hye Ham et al. Molecular Cancer
- Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance
- (2019) Meran Keshawa Ediriweera et al. SEMINARS IN CANCER BIOLOGY
- The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
- (2019) Dong-ming Wu et al. Cell Death & Disease
- Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines
- (2019) Mona Dawood et al. Frontiers in Pharmacology
- Progression-Related Loss of Stromal Caveolin 1 Levels Mediates Radiation Resistance in Prostate Carcinoma via the Apoptosis Inhibitor TRIAP1
- (2019) Julia Ketteler et al. Journal of Clinical Medicine
- Targeting the phosphoinositide 3-kinase/AKT pathways by small molecules and natural compounds as a therapeutic approach for breast cancer cells
- (2019) Amin Soltani et al. MOLECULAR BIOLOGY REPORTS
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
- (2019) Fengzhi Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
- (2019) Daphné Morel et al. Nature Reviews Clinical Oncology
- Targeting AKT for cancer therapy
- (2019) Maryam Shariati et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb
- (2019) Rittler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma
- (2019) Farzad Rahmani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The great escape: tumour cell plasticity in resistance to targeted therapy
- (2019) Soufiane Boumahdi et al. NATURE REVIEWS DRUG DISCOVERY
- Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
- (2019) Spencer C. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting oncogenic SOX2 in human cancer cells: therapeutic application
- (2019) Shizhen Zhang et al. Protein & Cell
- microRNA-181d-5p-containing exosomes derived from cancer-associated fibroblasts promote epithelial-mesenchymal transition by regulating CDX2/HOXA5 in breast cancer
- (2019) Hongbin Wang et al. Molecular Therapy-Nucleic Acids
- The timeline of epigenetic drug discovery: from reality to dreams
- (2019) A. Ganesan et al. Clinical Epigenetics
- BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
- (2018) Chaoyang Sun et al. CANCER CELL
- Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer
- (2018) Yongchen Ma et al. Cancer Cell International
- The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia
- (2018) Yu Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
- (2018) Joseph J. Caumanns et al. CLINICAL CANCER RESEARCH
- Role of miRNAs in cell signaling of cancer associated fibroblasts
- (2018) A.K. Eichelmann et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo
- (2018) Long-Bin Jeng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19
- (2018) Jing Ren et al. Theranostics
- Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2
- (2018) Deepa Srinivasan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The role of cellular reactive oxygen species in cancer chemotherapy
- (2018) Haotian Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor-related interleukins: old validated targets for new anti-cancer drug development
- (2017) Sarra Setrerrahmane et al. Molecular Cancer
- The cancer epigenome: Concepts, challenges, and therapeutic opportunities
- (2017) Mark A. Dawson SCIENCE
- Netrin-1 in cancer: Potential biomarker and therapeutic target?
- (2017) Umut Kefeli et al. TUMOR BIOLOGY
- Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index
- (2017) Jie Bai et al. Drug Design Development and Therapy
- IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
- (2017) Xiongyan Wu et al. Oncotarget
- Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma
- (2017) Mark E. Issa et al. Clinical Epigenetics
- Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance
- (2017) Heinz Hammerlindl et al. Journal of Cell Communication and Signaling
- Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells
- (2017) Dongya Zhang et al. Scientific Reports
- The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts
- (2016) Melanie Mediavilla-Varela et al. BMC CANCER
- Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways
- (2016) BO ZHOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- An analysis of the role of follicular lymphoma-associated fibroblasts to promote tumor cell viability following drug-induced apoptosis
- (2016) Annette M. Staiger et al. LEUKEMIA & LYMPHOMA
- Generation of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during Inflammation
- (2016) Juliane Lokau et al. MEDIATORS OF INFLAMMATION
- BCL2 Inhibitors as Anticancer Drugs: A Plethora of Misleading BH3 Mimetics
- (2016) R. S. Soderquist et al. MOLECULAR CANCER THERAPEUTICS
- The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer
- (2016) Kim Moran-Jones Molecular Diagnosis & Therapy
- Osthole shows the potential to overcome P-glycoprotein-mediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway
- (2016) HONG WANG et al. ONCOLOGY REPORTS
- Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
- (2016) Julia Beermann et al. PHYSIOLOGICAL REVIEWS
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance
- (2016) Yvonne Voges et al. Cell Death & Disease
- Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
- (2016) Michael Ramirez et al. Nature Communications
- Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin
- (2016) Chaojun Xue et al. Oncotarget
- Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence
- (2016) Ritesh Kotecha et al. Oncotarget
- The role of p53 in cancer drug resistance and targeted chemotherapy
- (2016) Karin Hientz et al. Oncotarget
- Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
- (2016) Leilei Tao et al. Scientific Reports
- Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma
- (2016) Yingqin Li et al. PLoS Genetics
- MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner
- (2016) Felix Y. Feng et al. NEOPLASIA
- Targeting CD73 in the tumor microenvironment with MEDI9447
- (2016) Carl M. Hay et al. OncoImmunology
- Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo
- (2015) Shu Yang et al. BMC CANCER
- How Do Cytotoxic Lymphocytes Kill Cancer Cells?
- (2015) L. Martinez-Lostao et al. CLINICAL CANCER RESEARCH
- SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling
- (2015) Hui Gao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer Microenvironment: What Can We Learn from the Stem Cell Niche
- (2015) Lukas Lacina et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interleukin-6 expression by interactions between gynecologic cancer cells and human mesenchymal stem cells promotes epithelial-mesenchymal transition
- (2015) KYEONG A SO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
- (2015) GEORGE MIHAI NITULESCU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
- (2015) Nan Chen et al. Journal of Thoracic Oncology
- HDAC inhibitors still need a home run, despite recent approval
- (2015) Malini Guha NATURE REVIEWS DRUG DISCOVERY
- p53 in survival, death and metabolic health: a lifeguard with a licence to kill
- (2015) Flore Kruiswijk et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance
- (2015) CAROLINE ADAMS et al. ONCOLOGY REPORTS
- Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
- (2015) YOSHINORI IMAMURA et al. ONCOLOGY REPORTS
- ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro
- (2015) Dan-Dan Yu et al. Oncotarget
- Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer Invasion
- (2015) Hideki Yamaguchi et al. Cancers
- Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform
- (2015) Li Ying et al. PLoS One
- Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence
- (2015) Mauro Finicelli et al. Oncotarget
- Epigallocatechin-3-Gallate Potentiates the Effect of Curcumin in Inducing Growth Inhibition and Apoptosis of Resistant Breast Cancer Cells
- (2014) Shengpeng Wang et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- PKCδ/midkine pathway drives hypoxia-induced proliferation and differentiation of human lung epithelial cells
- (2014) Hanying Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- The Role of Mechanical Forces in Tumor Growth and Therapy
- (2014) Rakesh K. Jain et al. Annual Review of Biomedical Engineering
- d-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells
- (2014) Christiana M. Neophytou et al. BIOCHEMICAL PHARMACOLOGY
- Colon cancer: Cancer stem cells markers, drug resistance and treatment
- (2014) Zuzana Kozovska et al. BIOMEDICINE & PHARMACOTHERAPY
- Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma
- (2014) L Chen et al. BRITISH JOURNAL OF CANCER
- Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)
- (2014) Chang Xia et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- 5-Azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation
- (2014) MATHIAS FÜLLER et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology
- (2014) Gabor Valcz et al. JOURNAL OF CLINICAL PATHOLOGY
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- Self-consumption: the interplay of autophagy and apoptosis
- (2014) Guillermo Mariño et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cost-Effectiveness Analysis of Hydralazine and Magnesium Valproate LP Associated With Treatment for Adult Patients with Metastatic Recurrent or Persistent Cervical Cancer in Mexico
- (2014) H. Soto et al. VALUE IN HEALTH
- Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling
- (2014) Wan-Jiun Chen et al. Nature Communications
- Overcoming multiple drug resistance mechanisms in medulloblastoma
- (2014) Ramadhan T Othman et al. Acta Neuropathologica Communications
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
- (2014) Martin Augsten Frontiers in Oncology
- Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins
- (2013) Lan Yang et al. APOPTOSIS
- Fibroblast-mediated drug resistance in cancer
- (2013) Kim H.T. Paraiso et al. BIOCHEMICAL PHARMACOLOGY
- Sox2 promotes tamoxifen resistance in breast cancer cells
- (2013) Marco Piva et al. EMBO Molecular Medicine
- Reprogramming cell death: BCL2 family inhibition in hematological malignancies
- (2013) Lydia Scarfò et al. IMMUNOLOGY LETTERS
- Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies
- (2013) Gerald S. Falchook et al. INVESTIGATIONAL NEW DRUGS
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Interleukin-6 Mediates Epithelial–Stromal Interactions and Promotes Gastric Tumorigenesis
- (2013) Hiroto Kinoshita et al. PLoS One
- Functional Investigation of NCI-H460-Inducible Myofibroblasts on the Chemoresistance to VP-16 with a Microfluidic 3D Co-Culture Device
- (2013) Yuanyuan Hao et al. PLoS One
- Difluorinated-Curcumin (CDF) Restores PTEN Expression in Colon Cancer Cells by Down-Regulating miR-21
- (2013) Sanchita Roy et al. PLoS One
- MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
- (2013) Jessica Bockhorn et al. Nature Communications
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
- (2012) Roel H. Wilting et al. DRUG RESISTANCE UPDATES
- Targeting the Bcl-2 family for cancer therapy
- (2012) Shibu Thomas et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- ERβ-Mediated Estradiol Enhances Epithelial Mesenchymal Transition of Lung Adenocarcinoma through Increasing Transcription of Midkine
- (2012) Guangfeng Zhao et al. MOLECULAR ENDOCRINOLOGY
- High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level
- (2012) Chunsen Xu et al. Breast Cancer
- Akt, FoxO and regulation of apoptosis
- (2011) Xinbo Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Midkine induces epithelial-mesenchymal transition through Notch2/Jak2-Stat3 signaling in human keratinocytes
- (2011) Yiping Huang et al. CELL CYCLE
- Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action
- (2011) M Lorente et al. CELL DEATH AND DIFFERENTIATION
- Synergistic Activity of Fenretinide and the Bcl-2 Family Protein Inhibitor ABT-737 against Human Neuroblastoma
- (2011) H. Fang et al. CLINICAL CANCER RESEARCH
- Apoptotic cell signaling in cancer progression and therapy
- (2011) Jessica Plati et al. Integrative Biology
- Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line-specific apoptotic mechanisms
- (2011) Prema S. Rao et al. INTERNATIONAL JOURNAL OF CANCER
- Novel Mechanism of Anti-apoptotic Function of 78-kDa Glucose-regulated Protein (GRP78)
- (2011) Hui Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
- (2011) Ronan J Kelly et al. Molecular Cancer
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
- (2011) R. A. Juergens et al. Cancer Discovery
- Survivin and IAP proteins in cell-death mechanisms
- (2010) Dario C. Altieri BIOCHEMICAL JOURNAL
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- Caspase activation pathways: some recent progress
- (2009) S P Cullen et al. CELL DEATH AND DIFFERENTIATION
- Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer
- (2009) T. Yamada et al. CLINICAL CANCER RESEARCH
- BH3-only proteins: The death-puppeteer's wires
- (2009) Fabio Ghiotto et al. CYTOMETRY PART A
- Life and death by death receptors
- (2009) Maria Eugenia Guicciardi et al. FASEB JOURNAL
- Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model
- (2009) Ajaikumar B. Kunnumakkara et al. INTERNATIONAL JOURNAL OF CANCER
- Human Caspases: Activation, Specificity, and Regulation
- (2009) Cristina Pop et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cytoplasmic functions of the tumour suppressor p53
- (2009) Douglas R. Green et al. NATURE
- BH3-only proteins and their roles in programmed cell death
- (2009) M Giam et al. ONCOGENE
- The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt
- (2009) P R Somanath et al. ONCOGENE
- Resveratrol down-regulates survivin and induces apoptosis in human multidrug-resistant SPC-A-1/CDDP cells
- (2009) Zhao ONCOLOGY REPORTS
- Glucose-regulated protein 78: A new partner of p53 in trophoblast
- (2009) Serge Arnaudeau et al. PROTEOMICS
- Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression
- (2008) R. F. Hwang et al. CANCER RESEARCH
- mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels
- (2008) Sandra E. Ghayad et al. CANCER SCIENCE
- Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
- (2008) A. C. Mita et al. CLINICAL CANCER RESEARCH
- The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
- (2008) Amancio Carnero et al. CURRENT CANCER DRUG TARGETS
- ROS and p53: A versatile partnership
- (2008) Bin Liu et al. FREE RADICAL BIOLOGY AND MEDICINE
- IAP-targeted therapies for cancer
- (2008) E C LaCasse et al. ONCOGENE
- Caspases in apoptosis and beyond
- (2008) J Li et al. ONCOGENE
- Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis
- (2008) P. G. Rychahou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas
- (2008) K. D. Mason et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Over-expressed and truncated midkines promote proliferation of BGC823 cells in vitro and tumor growth in vivo
- (2008) Qing-Ling Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search